Supreme Court Allows $124 Million Judgment Against Drug Company to Stand
According to a news article, the U.S. Supreme Court recently refused to hear a drug-maker’s appeal in a case that cost the drug company $124 million for falsely marketing a prescription medication. By declining the appeal, the court affirmed a South Carolina Supreme Court ruling that reduced the company’s damages from $327 million to $124 million, but it did not overturn a jury’s verdict that the drug company had improperly marketed the medication.
How Cases Get to the Supreme Court
Cases come to the supreme court in one of two ways. First, a case can be appealed to the court from a lower federal court ruling. These courts are called federal circuit courts. Second, a case can come to the supreme court from a state’s highest court. In either case, if the supreme court does not accept the appeal, the lower court’s decision stands.
What Happened in This Case?
The drug at issue in the South Carolina case is called Risperdal. Risperdal was introduced in 1994 for the treatment of schizophrenia and bipolar disorder. It is also given to patients with autism who suffer from irritability and aggressiveness. Side effects of the medication include diabetes, stroke, and weight gain.